Press Release: Variant Bio : Variant Bio Turns Toward Discovery of Novel Medicines, Marking a New Chapter of Growth for the Company

David Moller joins as Chief Scientific Officer and Steve Bryant as Chief Business Officer, adding deep expertise to executive team SEATTLE--(BUSINESS WIRE)-- Variant Bio, a genomics-driven drug discovery company,...